Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE

A. K. Pavlou and J. M. Reichert, Recombinant protein therapeutics - success rates, market trends and values to 2010, Nature Biotechnol. 22 (2004) 1513-1519; DOI: 10.1038/nbt1204-1513.10.1038/nbt1204-1513Search in Google Scholar

A. C. Herman, T. C. Boone and S. Lu, Characterization, Formulation and Stability of Neupogen (Filgrastim), a Recombinant Human Granulocyte-colony Stimulating Factor, in Formulation, Characterization and Stability of Protein Drugs (Eds. R. Pearlman and Y. J. Wang), Plenum Press, New York 1996, pp. 303-328.10.1007/0-306-47452-2_7Search in Google Scholar

V. Gervais, A. Zerial and H. Oschkinat, NMR investigations of the role of the sugar moiety in glycosylated recombinant human G-CSF, Eur. J. Biochem. 247 (1997) 386-395.10.1111/j.1432-1033.1997.00386.xSearch in Google Scholar

C. Wang, M. Eufemi, C. Turano and A. Giartosio, Influence of the carbohydrate moiety on the stability of glycoproteins, Biochemistry 35 (1996) 7299-7307; DOI: 10.1021/bi9517704.10.1021/bi9517704Search in Google Scholar

C. Nissen, Glycosylation of recombinant human granulocyte-colony stimulating factor: implications for stability and potency, Eur. J. Cancer 30A (Suppl. 3) (1994) S12-S14.Search in Google Scholar

M. Oheda, M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K. Tomonou, T. Yamazaki and N. Ochi, O-linked sugar chain of hG-CSF protects it against polymerization and denaturation allowing it to retain its biological activity, J. Biol. Chem. 265 (1990) 11432-11436.10.1016/S0021-9258(19)38416-9Search in Google Scholar

A. Hüttmann, K. Schirsafi, S. Seeber and P. Bojko, Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation, J. Cancer Res. Clin. Oncol. 131 (2005) 152-156; DOI: 10.1007/s00432-004-0636-x.10.1007/s00432-004-0636-xSearch in Google Scholar

M. Hoglund, B. Smedmyr, M. Bengtsson, T. H. Totterman, U. Cour-Chabernaud and A. Yver, Mobilisation of CD34+ cells by glycosylated and non-glycosylated GSCF in healthy volunteers - A comparative study, Eur. J. Haematol. 59 (1997) 177-183.10.1111/j.1600-0609.1997.tb00972.xSearch in Google Scholar

W. Wang, Instability, stabilization, and formulation of liquid protein pharmaceuticals, Int. J. Pharm. 185 (1999) 129-188; DOI: 10.1016/S0378-5173(99)00152-0.10.1016/S0378-5173(99)00152-0Search in Google Scholar

E. Y. Chi, S. Krishnan, B. S. Kendrick, B. S. Chang, J. F. Carpenter and T. W. Randolph, Roles of conformational stability and colloidal stability in the aggregation of rHuG-CSF, Protein Sci. 12 (2003) 903-913.10.1110/ps.0235703Search in Google Scholar

S. Krishnan, E. Y. Chi, J. N. Webb, B. S. Chang, D. Shan, M. Goldenberg, M. C. Manning, T. W. Randolph and J. F. Carpenter, Aggregation of G-CSF under physiological conditions: Characterization and thermodynamic inhibition, Biochemistry 41 (2002) 6422-6431; DOI: 10.1021/bi 012006m.Search in Google Scholar

M. W. Bruner, J. Goldstein, C. R. Middaugh, M. A. Brooks and D. B. Volkin, Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations, J. Pharm. Biomed. Anal. 15 (1997) 1929-1935; DOI: 10.1016/S0731-7085(96)02043-2.10.1016/S0731-7085(96)02043-2Search in Google Scholar

K. Ahrer, A. Buchacher, G. Iberer and A. Jungbauer, Detection of aggregate formation during production of human immunoglobulin G by means of light scattering, J. Chromatogr. A 1043 (2004) 41-46; DOI: 10.1016/j.chroma.2004.05.024.10.1016/j.chroma.2004.05.02415317411Search in Google Scholar

R. S. Gunturi, I. Ghobrial and B. Sharma, Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of rHuEPO aggregates, J. Pharm. Biomed. Anal. 43 (2007) 213-221; DOI: 10.1016/j.jpba.2006.06.006.10.1016/j.jpba.2006.06.00616875794Search in Google Scholar

J. P. Gabrielson, M. L. Brader, A. H. Pekar, K. B. Mathis, G. Winter, J. F. Carpenter and T. W. Randolph, Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation and sedimentation velocity, J. Pharm. Sci. 96 (2007) 268-279; DOI: 10.1002/jps.20760.10.1002/jps.2076017080424Search in Google Scholar

C. F. Codevilla, L. Brum, P. R. de Oliveira, C. Dolman, B. Rafferty and S. L. Dalmora, Validation of an SEC-HPLC method for the analysis of rhG-CSF in pharmaceutical formulation, J. Liq. Chrom. 27 (2004) 2689-2698; DOI: 10.1081/JLC-200029121.10.1081/JLC-200029121Search in Google Scholar

S. W. Raso, J. Abel, J. M. Barnes, K. M. Maloney, G. Pipes, M. J. Treuheit, J. King and D. N. Brems, Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state, Protein Sci. 14 (2005) 2246-2257; DOI: 10.1110/ps.051489405.10.1110/ps.051489405225347916131655Search in Google Scholar

U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685; DOI: 10.1038/227680a0.10.1038/227680a05432063Search in Google Scholar

M. E. Cromwell, E. Hilario and F. Jacobson, Protein aggregation and bioprocessing, AAPS Journal 8 (2006) E572-E579; DOI: 10.1208/aapsj080366.10.1208/aapsj080366276106417025275Search in Google Scholar